177 related articles for article (PubMed ID: 25928893)
1. Association of Cone-Rod Homeobox Transcription Factor Messenger RNA With Pediatric Metastatic Retinoblastoma.
Torbidoni AV; Laurent VE; Sampor C; Ottaviani D; Vazquez V; Gabri MR; Rossi J; de Dávila MT; Alonso C; Alonso DF; Chantada GL
JAMA Ophthalmol; 2015 Jul; 133(7):805-12. PubMed ID: 25928893
[TBL] [Abstract][Full Text] [Related]
2. Minimal Disseminated Disease in Nonmetastatic Retinoblastoma With High-Risk Pathologic Features and Association With Disease-Free Survival.
Laurent VE; Torbidoni AV; Sampor C; Ottaviani D; Vazquez V; Gabri MR; Garcia de Davila MT; Ramirez-Ortiz MA; Alonso CN; Rossi J; Alonso DF; Chantada GL
JAMA Ophthalmol; 2016 Dec; 134(12):1374-1379. PubMed ID: 27787537
[TBL] [Abstract][Full Text] [Related]
3. Minimal disseminated disease evaluation and outcome in trilateral retinoblastoma.
Torbidoni AV; Sampor C; Laurent VE; Aschero R; Iyer S; Rossi J; Alderete D; Alonso DF; Szijan I; Chantada GL
Br J Ophthalmol; 2018 Nov; 102(11):1597-1601. PubMed ID: 30150278
[TBL] [Abstract][Full Text] [Related]
4. Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination.
Pascual-Pasto G; Olaciregui NG; Vila-Ubach M; Paco S; Monterrubio C; Rodriguez E; Winter U; Batalla-Vilacis M; Catala J; Salvador H; Parareda A; Schaiquevich P; Suñol M; Mora J; Lavarino C; de Torres C; Chantada GL; Carcaboso AM
Cancer Lett; 2016 Sep; 380(1):10-9. PubMed ID: 27319373
[TBL] [Abstract][Full Text] [Related]
5. Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA.
Laurent VE; Sampor C; Solernou V; Rossi J; Gabri M; Eandi-Eberle S; de Davila MT; Alonso DF; Chantada GL
Eur J Cancer; 2013 Sep; 49(13):2892-9. PubMed ID: 23721779
[TBL] [Abstract][Full Text] [Related]
6. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
Dimaras H; Rushlow D; Halliday W; Doyle JJ; Babyn P; Abella EM; Williams J; Héon E; Gallie BL; Chan HS
Transl Res; 2010 Aug; 156(2):91-7. PubMed ID: 20627193
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of CRX in extracranial malignant small round cell tumors.
Terry J; Calicchio ML; Rodriguez-Galindo C; Perez-Atayde AR
Am J Surg Pathol; 2012 Aug; 36(8):1165-9. PubMed ID: 22790857
[TBL] [Abstract][Full Text] [Related]
8. Assessment of retinoblastoma RNA reflux after intravitreal injection of melphalan.
Winter U; Nicolas M; Sgroi M; Sampor C; Torbidoni A; Fandiño A; Chantada GL; Munier FL; Schaiquevich P
Br J Ophthalmol; 2018 Mar; 102(3):415-418. PubMed ID: 29089355
[TBL] [Abstract][Full Text] [Related]
9. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
[TBL] [Abstract][Full Text] [Related]
10. Metastatic retinoblastoma clinical features, treatment, and prognosis.
Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
[TBL] [Abstract][Full Text] [Related]
11. Differential CRX and OTX2 expression in human retina and retinoblastoma.
Glubrecht DD; Kim JH; Russell L; Bamforth JS; Godbout R
J Neurochem; 2009 Oct; 111(1):250-63. PubMed ID: 19686387
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow aspirations and lumbar punctures in retinoblastoma at diagnosis: correlation with IRSS staging.
Bakhshi S; Meel R; Kashyap S; Sharma S
J Pediatr Hematol Oncol; 2011 Jul; 33(5):e182-5. PubMed ID: 21364467
[TBL] [Abstract][Full Text] [Related]
13. The effect of retinoids and butyrate on the expression of CRX and IRBP in retinoblastoma cells.
Boatright JH; Stodulkova E; Do VT; Padove SA; Nguyen HT; Borst DE; Nickerson JM
Vision Res; 2002 Apr; 42(8):933-8. PubMed ID: 11934446
[TBL] [Abstract][Full Text] [Related]
14. Minimally disseminated disease and outcome in overt orbital retinoblastoma.
Aschero R; Torbidoni A; Sampor C; Laurent V; Zugbi S; Winter U; Lubieniecki F; Alonso D; Schaiquevich P; Chantada GL
Pediatr Blood Cancer; 2019 Jun; 66(6):e27662. PubMed ID: 30803140
[TBL] [Abstract][Full Text] [Related]
15. Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients.
Chantada GL; Sampor C; Bosaleh A; Solernou V; Fandiño A; de Dávila MT
JAMA Ophthalmol; 2013 Sep; 131(9):1127-34. PubMed ID: 23787805
[TBL] [Abstract][Full Text] [Related]
16. An aggressive bone marrow evaluation including immunocytology with GD2 for advanced retinoblastoma.
Chantada GL; Rossi J; Casco F; Fandiño A; Scopinaro M; de Dávila MT; Abramson DH
J Pediatr Hematol Oncol; 2006 Jun; 28(6):369-73. PubMed ID: 16794505
[TBL] [Abstract][Full Text] [Related]
17. Gene expression networks underlying retinoic acid-induced differentiation of human retinoblastoma cells.
Li A; Zhu X; Brown B; Craft CM
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):996-1007. PubMed ID: 12601020
[TBL] [Abstract][Full Text] [Related]
18. CRX is a diagnostic marker of retinal and pineal lineage tumors.
Santagata S; Maire CL; Idbaih A; Geffers L; Correll M; Holton K; Quackenbush J; Ligon KL
PLoS One; 2009 Nov; 4(11):e7932. PubMed ID: 19936203
[TBL] [Abstract][Full Text] [Related]
19. More aggressive bone marrow screening in retinoblastoma patients is not indicated: the memorial Sloan-Kettering cancer center experience.
Zacharoulis S; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2006 Jan; 46(1):56-61. PubMed ID: 16123998
[TBL] [Abstract][Full Text] [Related]
20. Novel 615delC mutation in the CRX gene in a Japanese family with cone-rod dystrophy.
Itabashi T; Wada Y; Sato H; Kawamura M; Shiono T; Tamai M
Am J Ophthalmol; 2004 Nov; 138(5):876-7. PubMed ID: 15531334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
